Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.
The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.
Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.
Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。